IRIS UniCatt

Bria, Pietro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.180
EU - Europa 5.929
AS - Asia 4.336
SA - Sud America 768
AF - Africa 109
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 7
Totale 17.360
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.032
DE - Germania 2.168
SG - Singapore 2.030
CN - Cina 1.148
IT - Italia 853
SE - Svezia 731
BR - Brasile 636
UA - Ucraina 605
FR - Francia 548
VN - Vietnam 355
GB - Regno Unito 302
IE - Irlanda 202
IN - India 160
FI - Finlandia 142
ID - Indonesia 139
RU - Federazione Russa 124
JP - Giappone 88
PL - Polonia 68
TR - Turchia 67
BD - Bangladesh 66
CA - Canada 60
MX - Messico 58
HK - Hong Kong 53
AR - Argentina 46
NL - Olanda 43
AU - Australia 30
IQ - Iraq 29
BE - Belgio 26
ZA - Sudafrica 25
ES - Italia 24
CI - Costa d'Avorio 22
SA - Arabia Saudita 21
IR - Iran 19
KR - Corea 18
MA - Marocco 16
EC - Ecuador 15
PK - Pakistan 15
VE - Venezuela 15
EG - Egitto 14
PY - Paraguay 14
CH - Svizzera 13
AT - Austria 12
CL - Cile 12
CO - Colombia 12
IL - Israele 12
LT - Lituania 11
PH - Filippine 11
PE - Perù 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
UZ - Uzbekistan 9
JO - Giordania 8
NP - Nepal 8
TN - Tunisia 8
TW - Taiwan 8
BG - Bulgaria 7
BY - Bielorussia 7
LB - Libano 7
AL - Albania 6
DZ - Algeria 6
RO - Romania 6
TT - Trinidad e Tobago 6
CR - Costa Rica 5
CZ - Repubblica Ceca 5
HU - Ungheria 5
KE - Kenya 5
KZ - Kazakistan 5
MY - Malesia 5
NO - Norvegia 5
OM - Oman 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
JM - Giamaica 4
LK - Sri Lanka 4
PA - Panama 4
TH - Thailandia 4
A1 - Anonimo 3
ET - Etiopia 3
GE - Georgia 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
RS - Serbia 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
CY - Cipro 2
EU - Europa 2
GR - Grecia 2
HR - Croazia 2
LV - Lettonia 2
MC - Monaco 2
NI - Nicaragua 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
AD - Andorra 1
BJ - Benin 1
Totale 17.342
Salva come PNG Salva come JPEG
Città #
Singapore 1.114
Chandler 861
Ashburn 742
San Jose 519
Jacksonville 331
San Mateo 245
Dublin 198
Beijing 183
Nanjing 183
Milan 175
Wilmington 157
Nürnberg 124
Jakarta 121
Dearborn 120
Ho Chi Minh City 120
Woodbridge 119
New York 118
Los Angeles 113
Bremen 106
Rome 104
Lauterbourg 103
Hanoi 101
Houston 96
Hefei 91
Redwood City 90
Boston 85
Ann Arbor 77
Nanchang 77
Seattle 73
Moscow 69
Lawrence 68
Tokyo 67
Frankfurt am Main 66
São Paulo 59
Munich 54
University Park 53
Marseille 48
Princeton 48
Norwalk 46
Hong Kong 45
Mountain View 44
Lancaster 40
Paris 40
Fairfield 36
Buffalo 34
Hebei 33
Kent 32
Cattolica 31
Dallas 31
Guangzhou 30
Kunming 30
Shanghai 30
Shenyang 28
Boardman 27
Tianjin 27
Warsaw 27
Cambridge 26
Fremont 26
Hangzhou 26
Izmir 25
Brooklyn 23
Abidjan 22
Atlanta 22
Changsha 22
Falls Church 22
Helsinki 22
Kraków 22
Chennai 21
Columbus 21
Andover 20
Da Nang 20
Düsseldorf 20
Rio de Janeiro 20
Brussels 19
Philadelphia 19
Santa Clara 19
Bologna 18
Mexico City 18
The Dalles 18
Chicago 17
London 17
Menlo Park 17
Porto Alegre 17
Jiaxing 16
Orem 16
Belo Horizonte 15
Pune 15
Baghdad 14
Brasília 14
Montreal 14
Stockholm 14
Haiphong 13
Johannesburg 13
Saint-Ouen-l'Aumone 13
Augusta 12
Bexley 12
Detroit 12
Portsmouth 12
Sydney 12
Bragança 10
Totale 8.475
Salva come PNG Salva come JPEG
Nome #
Behavioural addictions in bipolar disorder patients: Role of impulsivity and personality dimensions 277
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 268
Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. 264
Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial 262
Plasma cortisol levels and resilience in depressed patients 257
Programma di trattamento integrato in regime di day hospital per pazienti depressi “difficili” da trattare. 251
Bipolar Disorder Questionnaire for the Assessment of Learning: a New Instrument for Studying Information Acquisition in Psychoeducational programs. 241
Cognitive markers of psychotic unipolar depression: A meta-analytic study 237
Neuroendocrinologia dei disturbi dell umore 230
Augmentation of drug treatment with bright light therapy in patients with difficult-to-treat depression: acute and long term observation 220
Plasma magnesium level and psychomotor retardation in major depressed patients 215
Dopamine transporter availability and psychomotor retardation in major depression 215
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study] 211
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up. 211
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 210
Predicting treatment outcome in difficult-to-treat depressed patients 201
Striatal dopamine transporter (DAT) availability and affective symptoms in movement disorders: a 123I-FP-CIT SPECT study. 200
Problematic mobile phone use in adolescence: A cross-sectional study 195
Role of Substance Abuse Comorbidity and Personality on the Outcome of Depression in Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome. 194
Modulation of motor cortex neuronal networks by rTMS: comparison of local and remote effects of six different protocols of stimulation 194
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study]. 189
A day treatment programme on mood disorders: One-year activity outcomes 186
Sexual Behavior in Women with Bipolar Disorder 185
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 182
Plasma magnesium levels and treatment outcome in depressed patients 181
Non-Epileptic Seizures (NES) are predicted by depressive and dissociative symptoms 179
Internet addiction: hours spent online, behaviors and psychological symptoms 178
Affective temperaments and psychopathological dimensions of personality in bipolar and cyclothymic patients 177
Treatment of prurigo nodularis with pregabalin. 176
Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: depression vs. sub-threshold mixed state 173
Correlations Between Striatal Dopamine Transporter (DAT) Availability and Psychiatric Symptoms in Movement Disorders: A 123I-FP-CIT SPECT Study. 171
Alcohol protracted withdrawal syndrome: the role of anhedonia 169
Polysomnographic Findings in a Cohort of Chronic Insomnia Patients with Benzodiazepines Abuse 165
An observational study evaluating comorbidity between bipolar disorder and personality disorders 164
Plasma magnesium levels and treatment outcome in depressed patients 163
Changes of Dopamine Transporter Availability in Depressed Patients with and without Anhedonia: A 123I-N-ω-Fluoropropyl-Carbomethoxy-3β-(4-Iodophenyl)tropane SPECT Study 162
Role of substance abuse comorbidity and personality on the outcome of depression in bipolar disorder: harm avoidance influences medium-term treatment outcome 161
Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. 160
Behavioural addictions in adolescents and young adults: results from a prevalence study. 159
Cognitive markers of psychotic unipolar depression: A meta-analytic study 159
Anhedonia and Cortisol Levels in Major Depression. 158
Psicopatologia nell’epilessia e nella pseudoepilessia: risultati preliminari nella nostra esperienza 157
Changing of dopamine transporter binding in depressed patients with anhedonia during treatment 155
Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up 155
Affective temperament and attachment in adulthood in patients with Bipolar Disorder and Cyclothymia 152
Hyperactivation of inflammatory response in depressed patients with psychomotor retardation 151
Somatic symptoms and high-sensitive C-reactive protein in major depression 150
Il trattamento della schizofrenia 150
Striatal dopamine transporter density in anhedonic depressed patients before and after pharmachological treatment 150
SNRI effective treatment does not restore changes of immune and inflammatory parameters in depressed patients 149
Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients 149
Oxcarbazepine in bipolar disorder: a critical review of the literature 146
Clinical correlates of difficult-to-treat depression: Exploring an integrated day-care model of treatment 146
What is the effect of selective serotonin reuptake inhibitors on temperament and character in patients with fibromyalgia? 145
Treatment of prurigo nodularis with pregabalin 145
Affective temperaments and psychopathological dimensions of personality in Bipolar Disorder 144
Predictive value of magnesium levels in depressed patients. 143
Plasma dehydroepiandrosterone sulphate (DHEAS) and cortisol in patients with mood disorders 143
Mood, hormones and quality of life. 142
Facial emotion recognition deficit in Amnestic Mild Cognitive Impairment and Alzheimer Disease 142
Duloxetine for premenstrual dysphoric disorder: a pilot study 140
Behavioural addictions in adolescents and young adults: results from a prevalence study 139
Depression and suicide in epilepsy: Fact or artefact? 138
The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables 137
Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding 137
La gestione della crisi suicidaria: dall'emergenza clinica alla riabilitazione del paziente 135
Enhanced BDNF serum levels in patients with severe pathological gambling 133
Analisi antropofenomenologica di un'esperienza in un'istituzione manicomiale del meridione 133
Plasma levels of n-3 fatty acids in bipolar patients: Deficit restricted to DHA 133
Cocaine use disorders and serum magnesium profile 132
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. 132
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview 131
Inflammatory response and psychopathological dimensions in major depression 131
Neuroendocrinology of mood disorders. 130
Venlafaxine: Successful treatment in impulsive disorders 129
Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers 129
Evidenze preliminari sulle modifiche del transporter della dopamina in pazienti depressi con rallentamento psicomotorio 129
Oxcarbazepine improves mood in patients with epilepsy. 128
Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. 128
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: An overview. 127
Major depressive disorder and dopamine transporter density: investigation by 123I-FP-CIT SPET 127
Ansia, depressione ed epilessia del lobo temporale 126
Sleep Disturbances and Depression: a review 124
Oxcarbazepine improves mood in patients with epilepsy 123
Enhanced BDNF serum levels in patients with severe pathological gambling 122
Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients 121
Effects of psychostimulants on neurotrophins implications for psychostimulant-induced neurotoxicity. 121
Functional neuroimaging: points of intersection between biology and psychotherapy. 119
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. 119
Reply to Dr Korczyn. 117
Bipolar disorder and epilepsy: a bidirectional relation? Neurobiological underpinnings, current hypotheses, and future research directions 117
Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients 115
Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. 113
Reply to Dr Corrao and colleagues. 110
Relating with migrants: ethnopsychiatry and psychotherapy 110
To be or not to be a bipolar disorder patient: problems with diagnosis. 109
DAT binding and psychopathological features in depressed patients. 108
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms 107
Valutazione dell esperienza di un gruppo di self-help in pazienti depressi in remissione parziale. 106
Efficacy and safety of pregabalin in alcohol dependence 105
Totale 15.934
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.173
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021290 0 0 0 0 0 0 0 0 0 92 178 20
2021/20221.102 109 135 19 61 40 26 34 193 40 70 169 206
2022/20232.407 297 362 160 409 196 273 121 161 297 22 74 35
2023/20241.003 48 303 23 44 37 112 42 34 35 51 154 120
2024/20252.265 120 108 159 117 208 90 49 149 351 189 388 337
2025/20264.944 807 132 290 540 985 262 901 276 340 411 0 0
Totale 17.504